These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 8573778

  • 1. Dysmyelination in class I MHC transgenic mice.
    Turnley AM, Morahan G.
    Microsc Res Tech; 1995 Nov 01; 32(4):286-94. PubMed ID: 8573778
    [Abstract] [Full Text] [Related]

  • 2. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes.
    Turnley AM, Morahan G, Okano H, Bernard O, Mikoshiba K, Allison J, Bartlett PF, Miller JF.
    Nature; 1991 Oct 10; 353(6344):566-9. PubMed ID: 1717849
    [Abstract] [Full Text] [Related]

  • 3. Major histocompatibility complex heavy chain accumulation in the endoplasmic reticulum of oligodendrocytes results in myelin abnormalities.
    Baerwald KD, Corbin JG, Popko B.
    J Neurosci Res; 2000 Jan 15; 59(2):160-9. PubMed ID: 10650874
    [Abstract] [Full Text] [Related]

  • 4. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
    Massa PT, Wu C, Fecenko-Tacka K.
    J Neurosci Res; 2004 Jul 01; 77(1):15-25. PubMed ID: 15197735
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CD44 overexpression by oligodendrocytes: a novel mouse model of inflammation-independent demyelination and dysmyelination.
    Tuohy TM, Wallingford N, Liu Y, Chan FH, Rizvi T, Xing R, Bebo B, Rao MS, Sherman LS.
    Glia; 2004 Sep 01; 47(4):335-45. PubMed ID: 15293231
    [Abstract] [Full Text] [Related]

  • 12. A transgenic mouse model for inducible and reversible dysmyelination.
    Mathis C, Hindelang C, LeMeur M, Borrelli E.
    J Neurosci; 2000 Oct 15; 20(20):7698-705. PubMed ID: 11027231
    [Abstract] [Full Text] [Related]

  • 13. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
    Kuhlmann T, Lucchinetti C, Zettl UK, Bitsch A, Lassmann H, Brück W.
    Glia; 1999 Oct 15; 28(1):34-9. PubMed ID: 10498820
    [Abstract] [Full Text] [Related]

  • 14. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J, Jagemann B, Wiegard C, Lazaro JF, Lueth S, Kanzler S, Blessing M, Schmitt E, Lohse AW.
    Hepatology; 2003 May 15; 37(5):1079-85. PubMed ID: 12717388
    [Abstract] [Full Text] [Related]

  • 15. Detailed in vivo analysis of interferon-gamma induced major histocompatibility complex expression in the the central nervous system: astrocytes fail to express major histocompatibility complex class I and II molecules.
    Horwitz MS, Evans CF, Klier FG, Oldstone MB.
    Lab Invest; 1999 Feb 15; 79(2):235-42. PubMed ID: 10068211
    [Abstract] [Full Text] [Related]

  • 16. MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis.
    Harrington EP, Catenacci RB, Smith MD, Heo D, Miller CE, Meyers KR, Glatzer J, Bergles DE, Calabresi PA.
    Elife; 2023 Apr 14; 12():. PubMed ID: 37057892
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Non-MHC-restricted cell-mediated lysis of human oligodendrocytes in vitro: relation with CD56 expression.
    Antel JP, McCrea E, Ladiwala U, Qin YF, Becher B.
    J Immunol; 1998 Feb 15; 160(4):1606-11. PubMed ID: 9469416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.